CG MedTech Co.,Ltd. (KOSDAQ:056090)
South Korea · Delayed Price · Currency is KRW 2,140.00
-115.00 (-5.10%)
At close: Apr 2, 2026
CG MedTech Revenue
In the year 2025, CG MedTech had annual revenue of 47.23B KRW with 36.43% growth. CG MedTech had revenue of 11.50B in the quarter ending December 31, 2025, with 16.68% growth.
Revenue
47.23B
Revenue Growth
+36.43%
P/S Ratio
4.68
Revenue / Employee
393.62M
Employees
120
Market Cap
220.97B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 47.23B | 12.61B | 36.43% |
| Dec 31, 2024 | 34.62B | -345.79M | -0.99% |
| Dec 31, 2023 | 34.97B | -6.20B | -15.06% |
| Dec 31, 2022 | 41.17B | 3.11B | 8.18% |
| Dec 31, 2021 | 38.06B | 10.28B | 37.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| KM Corporation | 135.41B |
| JW Shinyak | 81.04B |
| Sewoon Medical | 63.66B |
| OSTEONIC | 45.39B |
| DuChemBIO | 38.57B |
| Wonbiogen | 34.38B |
| Billions | 25.31B |
| SCL Science | 16.32B |